Advertisement

Dickdarm pp 511-535 | Cite as

Verlauf und Prognose

  • K. Müller-Wieland
Part of the Handbuch der inneren Medizin book series (INNEREN, volume 3 / 4)

Zusammenfassung

Bei Erkrankungen, deren Manifestation eine große Varianz zeigen und die erhebliche Quoten an Spontanremissionen aufweisen, gestatten nur kontrollierte Studien des Verlaufes eine Aussage über ihre Beeinflußbarkeit durch die Thera-pie. Über die Ursache oder die Bedeutung bestimmter pathogenetischer Prozesse bei der Rückfallsneigung der Colitis ulcerosa und des Morbus Crohn im Kolon ist nichts Sicheres bekannt. Manche Patienten bleiben über Jahre von alien Symptomen frei, während andere wiederholt Rückfälle erleiden, obgleich sich beide Populationen bezüglich Alter, Geschlecht und Ausdehnung der Erkran-kung nicht voneinander unterscheiden. Besonders durch die Arbeiten von Sloan et al. (1950), EDWARDS und TRUELOVE (1963), GOLIGHER et al. (1968) und FAHRLÄNDER und SHALEV (1974) stehen Einblicke über den Verlauf der Colitis ulcerosa zur Verfügung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahren CL, Hulten LAG, Lindhagen J (1977) Pathological aspects in severe colitis. In: Gastrointestinal emergencies. Pergamon Press, OxfordGoogle Scholar
  2. Banks BM, Korelitz BI, Zetzel L (1957) The course of non-specific ulcerative colitis. Gastroenterology 32:983–1013PubMedGoogle Scholar
  3. Bargen J A, Jackman RJ, Kerr JG (1938) Studies of the life histories of patients with chronic ulcerative colitis (thromboulcerative colitis) with some suggestions for treatment. Ann Intern Med 12:339Google Scholar
  4. Baron JH, Connell AM, Kanaghinis TG, Lennard-Jones JE, Jones FA (1962 a) Out-patient treatment of ulcerative colitis. Comparism between three doses of oral prednisone. Br Med J 1:441CrossRefGoogle Scholar
  5. Baron JH, Connell AM, Lennard-Jones JE, Jones FA (1962 b) Sulphasalazine and salicylazosulphadi- midine in ulcerative colitis. Lancet 1:1094PubMedCrossRefGoogle Scholar
  6. Bercovitz ZT (1953) A long-term evaluation of modern methods in the treatment of chronic ulcerative creitis. NY State J Med 53:2200Google Scholar
  7. Bergman L, Krause U (1977) Crohn’s disease. Scand J Gastroenterol 12:937–944PubMedCrossRefGoogle Scholar
  8. Bockus HL, Roth JLA, Buchman E, Kaiser M, Staub WR, Finkelstein A, Valdes-Dapena A (1956) Life history of non-specific ulcerative colitis: relation to prognosis to anatomical and clinical varieties. Gastroenterologia (Basel) 86:549Google Scholar
  9. Bonnevie D, Binder V, Anthonisen P, Riis P (1974) The prognosis of ulcerative colitis. Scand J Gastroenterol 9:81–91Google Scholar
  10. Brooke BN (1956) Cortisone and ulcerative colitis: an adverse effect. Lancet II: 1175CrossRefGoogle Scholar
  11. Caprilli R, Vernia P, Torsoli A (1977) Fluid and acid-base imbalance. In: Gastrointestinal emergencies. Pergamon Press, OxfordGoogle Scholar
  12. Carleson R, Fristedt B, Philipson J (1962) Ulcerative colitis. A follow-up investigation of a 20-year primary material. Acta Med Scand 172:647PubMedCrossRefGoogle Scholar
  13. Cullinan ER, McDougall IP (1957) The natural history of ulcerative colitis. Lancet 1:487–489CrossRefGoogle Scholar
  14. DeDombal FT, Geffen N, Darnborough A, Watkinson G, Goligher JC (1968) Radiological appearences of ulcerative colitis: an evaluation of their clinical significance. Gut 9:157CrossRefGoogle Scholar
  15. DeDombal FT, Burton IL, Clamp SE, Goligher JC (1974) Short-term course and prognosis of Crohn’s disease. Gut 15:435–443CrossRefGoogle Scholar
  16. Demling L, Hegemann G, Classen M, Emde J (1969) Die Prognose der Colitis ulcerosa. Dtsch Med Wochenschr 94:247–253PubMedCrossRefGoogle Scholar
  17. Demole MJ, Pollina Ph-J (1958) Le pronostic de la rectocolite ulcerohemorrogique en function de sousevolution arterienne. Praxis 47:943PubMedGoogle Scholar
  18. Dennis C, Karlson KE (1961) Cancer risk in ulcerative colitis: formidability per patient year of late disease. Surgery 50:568Google Scholar
  19. Dick HP, Grayson NI, Carpenter RG, Pelrie A (1964) Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5:437–442PubMedCrossRefGoogle Scholar
  20. Edwards FC, Truelove SC (1963) The course and prognosis of ulcerative colitis. Gut 4:299–315PubMedCrossRefGoogle Scholar
  21. Evans JG (1971) Trends in mortality from ulcerative colitis in England and Wales. Gut 12:119–122PubMedCrossRefGoogle Scholar
  22. Fahrlander H (1966) Colitis ulcerosa. Dtsch Med Wochenschr 91:1953PubMedCrossRefGoogle Scholar
  23. Fahrlander H (1977) Klinik und Verlauf der ulcerosen Colitis. In: Kremer K, Kivelitz H (Hrsg) Colitis ulcerosa. Int. Symp. Diisseldorf, Juni 1976.Google Scholar
  24. Thieme, Stuttgart, Fahrlander H, Shalev E (1974a) Colitis ulcerosa. Dtsch Med Wochenschr 99:2141–2147CrossRefGoogle Scholar
  25. Fahrlander H, Shalev E (1974 b) Die Enterocolitis regionalis Crohn. Dtsch Med Wochenschr 99:2207–2214PubMedCrossRefGoogle Scholar
  26. Farmer RG, Hawk WA, Turnbull RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627PubMedGoogle Scholar
  27. Flood Ch, Cepor MS, Hiatt RB, Karush A (1956) Prognosis in chronic ulcerative colitis. J Chronic Dis 4:267PubMedCrossRefGoogle Scholar
  28. Gallagher ND, Goulston SJM, Wyndham N, Morrow W (1962) The management of fulminant ulcerative colitis. Gut 3:306–311PubMedCrossRefGoogle Scholar
  29. Goligher JC, DeDombal FT, Watts JM, Watkinson G (1968) Ulcerative colitis.Google Scholar
  30. Bailliere, Tindall & Cassell, London, Goligher JC, Hoffman DC, DeDombal FT (1970) Surgical treatment of severe attacks of ulcerative colitis with special reference to the adventage of early operation. Br Med J 4:703CrossRefGoogle Scholar
  31. Jalan KN, Prescoff RI, Sircus W, Card WI, McManns JPA, Falconer CWA, Small WP, Smith AN, Bruce I (1970) An experience of ulcerative colitis. II. Short term outcome. Gastroenterology 59:589–597PubMedGoogle Scholar
  32. Jarnum S, Jensen KB (1975) Fecal radioiodine excretion following intravenous injection of 131 J- albumin and 125-J-immunoglobuline G in chronic inflammatory disease. Gastroenterology 68:1433–1444PubMedGoogle Scholar
  33. Kirsner JB, Woert M van (1964) Irreversibility and Reversibility in ulcerative colitis. Med Clin North Am 48:143–157PubMedGoogle Scholar
  34. Kristensen E, Mosbech J (1977) Mortality from ulcerative colitis in Denmark 1960–1969. Scand J Gastroenterol 12:189–191PubMedGoogle Scholar
  35. Law DH, Steinberg H, Sleisenger NH (1961) Ulcerative colitis with onset after the age of fifty. Gastroenterology 41:457PubMedGoogle Scholar
  36. Lennard-Jones JE, Vivian AB (1960) Fulminating ulcerative colitis: recent experience in management. Br Med J 11:96CrossRefGoogle Scholar
  37. Lennard-Jones JE, Cooper EW, Newell AC, Wilson CWE, Jones FA (1962) Observations on idiopathic proctitis. Gut 3:201–206PubMedCrossRefGoogle Scholar
  38. Lennard-Jones JE, Misievicz J J, Parrish J A, Ritchie JK, Swarbrick ET, Williams ChB (1974) Prospective study of outpatients with extensive colitis. Lancet 1:1065–1067PubMedCrossRefGoogle Scholar
  39. Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC (1975) Assessment of severity in colitis: a preliminary study. Gut 16:579–584PubMedCrossRefGoogle Scholar
  40. Lennard-Jones JE, Ritchie JK, Zohrab WJ (1976) Proctocolitis and Crohn’s disease of the colon: a comparism of the clinical course. Gut 17:477–482PubMedCrossRefGoogle Scholar
  41. McDougall IPM (1964) The cancer risk in ulcerative colitis. Lancet 11:655CrossRefGoogle Scholar
  42. Mallett SJ, Lennard-Jones JE, Bingley J, Gilon E (1978) Colitis (Living with disease). Lancet 11:619–621CrossRefGoogle Scholar
  43. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM (1979) National Cooperative Crohn’s Disease Study: Factors determining recurrence of Crohn’s disease after surgery. Gastroenterology 77:907PubMedGoogle Scholar
  44. Mendeloff AI (1975) Crohn’s disease: What do recurrence rates mean? N Engl J Med 287:718–719CrossRefGoogle Scholar
  45. Misievicz II, Lennard-Jones JE, Connell AM, Baron JA, Jones FA (1965) Controlled trial of sulphasalazine in maintainance therapy for ulcerative colitis. Lancet 1:185–188CrossRefGoogle Scholar
  46. Morowitz DA, Kirsner JB (1969) Mortality in ulcerative colitis: 1930 to 1966. Gastroenterology 57:481PubMedGoogle Scholar
  47. Miiller-Wieland K (1971) Ergebnisse einer mathematisch-statistischen Analyse des Merkmalver- bundes der Colitis ulcerosa zur Prognose. Verh Dtsch Ges Inn Med 77:537Google Scholar
  48. Nefzger MD, Acheson ED (1963) Ulcerative colitis in the U.S. Army in 1944: Follow up with particular reference to mortality in cases and controls. Gut 4:183–191PubMedCrossRefGoogle Scholar
  49. Nugent FW, Veidenheimer MC, Zuberi S, Garabedian MM, Parikh NK (1970) Clinical course of ulcerative proctosigmoiditis. Am J Dig Dis 15:321–326PubMedCrossRefGoogle Scholar
  50. Prior P, Fielding JF, Waterhouse JA, Cooke WT (1970) Mortality in Crohn’s disease. Lancet 1:1135–1137PubMedCrossRefGoogle Scholar
  51. Pulvertaft CN (1964) The late results of gastric resection. Br J Surg 51:414PubMedCrossRefGoogle Scholar
  52. Ritchie JK, Powell-Tuck J, Lennard-Jones JE (1978) Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet 1:1140–1143PubMedCrossRefGoogle Scholar
  53. Sloan WP, Bargen JA, Gage RG (1950) Life histories of patients with chronic ulcerative colitis: a review of 2000 cases. Gastroenterology 16:25–38PubMedGoogle Scholar
  54. Storgaard L, Bischoff N, Henriksen FW, Fischerman K, Jarnum S (1979) Survival rate in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 14:225PubMedCrossRefGoogle Scholar
  55. Torsoli A (1977) Acute severe colitis. In: Gastrointestinal emergencies. Pergamon Press, Oxford, pp 59–61Google Scholar
  56. Truelove SC, Jewell DP (1974) Intesive intraveneous regimen for severe attacks of ulcerative coli tis. Lancet 1:1067–1070PubMedCrossRefGoogle Scholar
  57. Truelove SC, Pena AS (1976) Course and prognosis of Crohn’s disease. Gut 17:192–201PubMedCrossRefGoogle Scholar
  58. Truelove SC, Witts CJ (1955) Cortisone in ulcerative colitis: final report on an therapeutical trial. Br Med J 11:1041–1048CrossRefGoogle Scholar
  59. Truelove SC, Watkinson G, Draper G (1962) Comparison of corticosteroides and sulphasalazine therapy in ulcerative colitis. Br Med J II: 1708CrossRefGoogle Scholar
  60. Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW (1978) Further experience in the treatment of severe attacks of ulcerative colitis. Lancet II: 1086CrossRefGoogle Scholar
  61. Visick AH (1948) Measured radical gastrectomy: A review of 505 operations for peptic ulcer. Lancet 1:505 510Google Scholar
  62. Wall AJ, Kirsner JB (1975) Ulcerative colitis and Crohn’s disease of the Colon: symptoms, signs and laboratory aspects. In: Kirsner JB, Shorter RG (eds) Inflammatory bowel disease. Lea & Febiger, PhiladelphiaGoogle Scholar
  63. Wall AJ, Kirsner JB, Shorter RG (1975) Some observations on the course and prognosis of ulcerative colitis and Crohn’s disease. In: Kirsner JB, Shortner RG (eds) Inflammatory bowel disease. Lea & Febiger, PhiladelphiaGoogle Scholar
  64. Watkinson G (1958) Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium. Br Med J 11:1077–1082CrossRefGoogle Scholar
  65. Watts JM, DeDombal FT, Goligher JC (1966) The long-term prognosis of ulcerative colitis. Br Med J 1:1447–1453PubMedCrossRefGoogle Scholar
  66. Watts JM, DeDombal FT, Goligher JC (1966) The early course of ulcerative colitis. Gut 7:16–31PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • K. Müller-Wieland

There are no affiliations available

Personalised recommendations